These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2663616)

  • 21. [Real and false risks of hormonal contraceptives].
    Belaïsch J
    Gynakol Rundsch; 1984; 24 Suppl 1():12-9. PubMed ID: 6519541
    [No Abstract]   [Full Text] [Related]  

  • 22. [What measures should be instituted when taking a "pill" was forgotten?].
    Enters-Neumann G; Grospietsch G
    Med Monatsschr Pharm; 1994 Jan; 17(1):16-8. PubMed ID: 8127249
    [No Abstract]   [Full Text] [Related]  

  • 23. [The use of hormonal contraception in perimenopause is still a hazard?].
    Buttarelli M; Ghezzi F; Cromi A; Raio L; Franchi M
    Minerva Ginecol; 2001 Dec; 53(6):421-9. PubMed ID: 11723427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [19-year-old patient with thromboembolism caused by oral contraception].
    Pihusch R; de Coutre P; Salat C; Göhring P; Poley S; Hiller E
    Internist (Berl); 1996 Nov; 37(11):1163-6. PubMed ID: 9036113
    [No Abstract]   [Full Text] [Related]  

  • 25. [The practice guideline 'Hormonal contraception' (second revision) from the Dutch College of General Practitioners; a response from the perspective of obstetrics & gynaecology].
    Boukes FS; Van Der Does FE; Assendelft WJ
    Ned Tijdschr Geneeskd; 2004 Jul; 148(27):1367-8; author reply 1368. PubMed ID: 15283031
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hormonal contraception and risk of venous thromboembolism: When to ask for an assessment of hemostasis? Which parameters?].
    Plu-Bureau G; Horellou MH; Gompel A; Conard J
    Gynecol Obstet Fertil; 2008 Apr; 36(4):448-54. PubMed ID: 18424163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Does an increase in endogenous estradiol in treatment with low-dose ovulation inhibitors signify increased risk?].
    Kuhl H
    Geburtshilfe Frauenheilkd; 1991 Jun; 51(6):492. PubMed ID: 1889734
    [No Abstract]   [Full Text] [Related]  

  • 28. [Eye examinations in long-term use of hormonal contraceptives].
    Wild H; Benad A; Frahm R
    Dtsch Gesundheitsw; 1977; 32(9):414-7. PubMed ID: 406130
    [No Abstract]   [Full Text] [Related]  

  • 29. Commentary: Hormonal contraception and HIV acquisition--current evidence and ongoing research needs.
    Morrison CS
    Int J Epidemiol; 2007 Feb; 36(1):175-7. PubMed ID: 17251242
    [No Abstract]   [Full Text] [Related]  

  • 30. [Contraception in risk patients. Discussion].
    Detering K; Hartmann E
    Med Welt; 1980 Dec; 31(49):1805-6. PubMed ID: 7207122
    [No Abstract]   [Full Text] [Related]  

  • 31. Oral contraceptives and venous thromboembolic events.
    Shulman LP; Goldzieher JW; Minkin MJ; Sulak PJ; Thorneycroft I
    J Reprod Med; 2003 Apr; 48(4):306-7. PubMed ID: 12747000
    [No Abstract]   [Full Text] [Related]  

  • 32. [Hormonal contraception--thromboembolic disorders and surgical risk (author's transl)].
    Göretzlehner G; Frick G; Frick U
    Zentralbl Chir; 1976; 101(18):1103-11. PubMed ID: 983453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Female hormones and benign liver tumours.
    La Vecchia C; Tavani A
    Dig Liver Dis; 2006 Aug; 38(8):535-6. PubMed ID: 16753350
    [No Abstract]   [Full Text] [Related]  

  • 34. [Hormonal contraceptives and myocardial infarct].
    Sefidpar M; Bieler M; Reutter FW
    Schweiz Med Wochenschr; 1975 Jun; 105(26):836-9. PubMed ID: 1215881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lipid metabolism and hormonal contraceptives].
    Klinger G
    Z Arztl Fortbild (Jena); 1990; 84(1-2):35-8. PubMed ID: 2184597
    [No Abstract]   [Full Text] [Related]  

  • 36. [Voice disorders following the use of hormonal contraceptives].
    Pahn J; Göretzlehner G
    Zentralbl Gynakol; 1978; 100(6):341-6. PubMed ID: 654668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The clinico-pharmacological characteristics of hormonal contraceptives for enteral use].
    Korkhov VV
    Farmakol Toksikol; 1990; 53(1):77-80. PubMed ID: 2328809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Health risks of estrogen medication?].
    Duursma SA
    Lebensversicher Med; 1987 Sep; 39(5):130-6. PubMed ID: 2890067
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormonal contraception: the current situation.
    Elstein M
    Practitioner; 1975 Oct; 215(1288):508-19. PubMed ID: 1202471
    [No Abstract]   [Full Text] [Related]  

  • 40. [The patient record of the use of hormonal contraceptives--a possibility for better monitoring].
    Canzler E; Bock H; Zipprich KW
    Zentralbl Gynakol; 1985; 107(16):1017-9. PubMed ID: 4050190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.